This session will:
- Recognize the current state of the art for treatment of malignant pleural mesothelioma.
- Provide updated results of recently completed studies.
- Identify the major, ongoing and planned clinical trials most likely to impact patient care in the near future.
Raffit Hassan, M.D.
Co-Chief, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
Program Chair- Ramaswamy Govindan, MD
Director, Section of Medical Oncology, Professor of Medicine, Anheuser-Busch Endowed Chair in Medical Oncology, Director, Section of Oncology, Washington University School of Medicine.
For any inquiries, please contact meetings@iaslc.org.
Raffit Hassan, M.D.
Co-Chief, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
Program Chair- Ramaswamy Govindan, MD
Director, Section of Medical Oncology, Professor of Medicine, Anheuser-Busch Endowed Chair in Medical Oncology, Director, Section of Oncology, Washington University School of Medicine.
For any inquiries, please contact meetings@iaslc.org.